A new integrative risk score predicts the risk of Crohn’s disease in healthy first-degree relatives of individuals with the ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

Learn why white rice, mashed potatoes, fruits without the skin, and other low-fiber and low-residue foods are your best bet ...

The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...

Amelenodor is under clinical development by AbbVie and currently in Phase I for Crohn's Disease (Regional Enteritis).

If you have an inflammatory bowel disease like Crohn’s or ulcerative colitis and have trouble focusing or remembering things, ...

"Our study suggests that vedolizumab is a viable option for induction and long-term maintenance therapy in children with IBD, ...

RS-1805 is under clinical development by Reistone Biopharma and currently in Phase I for Crohn's Disease (Regional Enteritis).

The multicentre, prospective, cohort study by Ohad Atia and colleagues1 on the long-term efficacy and safety of maintenance vedolizumab in paediatric patients with inflammatory bowel disease (IBD) ...

Alzheimer’s disease could be diagnosed up to a decade earlier after the world’s biggest study of proteins is completed. The ...

Researchers sought to estimate the prevalence and likelihood of fatigue among patients with IBD 1 year following diagnosis, categorized by different disease remissions.

Odds of complications significantly reduced with early anti-TNFα therapy, especially in those with perianal lesions ...